Free Trial
NASDAQ:GDRX

GoodRx Q2 2025 Earnings Report

GoodRx logo
$4.72 -0.01 (-0.11%)
As of 02:04 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

GoodRx EPS Results

Actual EPS
N/A
Consensus EPS
$0.10
Beat/Miss
N/A
One Year Ago EPS
N/A

GoodRx Revenue Results

Actual Revenue
N/A
Expected Revenue
$205.72 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

GoodRx Announcement Details

Quarter
Q2 2025
Time
After Market Closes
Conference Call Date
Wednesday, August 6, 2025
Conference Call Time
8:00AM ET

Conference Call Resources

GoodRx Earnings Headlines

GoodRx Holdings, Inc. (GDRX) Cash Flow - Yahoo Finance
The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.
GoodRx: A One Big Beautiful Bill Act Beneficiary
See More GoodRx Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like GoodRx? Sign up for Earnings360's daily newsletter to receive timely earnings updates on GoodRx and other key companies, straight to your email.

About GoodRx

GoodRx (NASDAQ:GDRX) operates a leading digital platform that helps consumers across the United States find and compare prescription drug prices at retail pharmacies. Through its website and mobile applications, the company aggregates real-time pricing data from pharmacies and pharmacy benefit managers to deliver coupons, discount cards, and pricing insights. This model enables individuals—whether uninsured, underinsured, or insured with high deductibles—to reduce out-of-pocket costs on a broad range of medications.

Beyond prescription savings, GoodRx offers telehealth services under the GoodRx Care brand, providing virtual medical consultations for non-emergency conditions such as allergies, skin issues, and sexual health concerns. Patients can connect with licensed healthcare professionals online to obtain diagnoses, treatment plans, and e-prescriptions, streamlining access to care and the subsequent procurement of affordable medications. The company also introduced GoodRx Gold, a subscription plan that delivers deeper discounts and additional member benefits.

Founded in 2011 by Douglas Hirsch and Trevor Bezdek, GoodRx has evolved through strategic partnerships and acquisitions. Early collaborations with national pharmacies and pharmacy benefit managers established its pricing database, while acquisitions like HeyDoctor expanded its telehealth capabilities. The launch of RxSaver further broadened the company’s reach by offering additional savings tools to both consumers and pharmacy chains.

Headquartered in Santa Monica, California, GoodRx focuses exclusively on the U.S. market. Under the leadership of CEO Douglas Hirsch and a management team experienced in technology, healthcare, and consumer services, the company continues to refine its digital offerings. Emphasizing affordability and convenience, GoodRx aims to transform how patients access and pay for prescription medications and basic healthcare services.

View GoodRx Profile

More Earnings Resources from MarketBeat